215 related articles for article (PubMed ID: 36843541)
21. Alternative splicing redefines landscape of commonly mutated genes in acute myeloid leukemia.
Rivera OD; Mallory MJ; Quesnel-Vallières M; Chatrikhi R; Schultz DC; Carroll M; Barash Y; Cherry S; Lynch KW
Proc Natl Acad Sci U S A; 2021 Apr; 118(15):. PubMed ID: 33876749
[TBL] [Abstract][Full Text] [Related]
22. Complex landscape of alternative splicing in myeloid neoplasms.
Hershberger CE; Moyer DC; Adema V; Kerr CM; Walter W; Hutter S; Meggendorfer M; Baer C; Kern W; Nadarajah N; Twardziok S; Sekeres MA; Haferlach C; Haferlach T; Maciejewski JP; Padgett RA
Leukemia; 2021 Apr; 35(4):1108-1120. PubMed ID: 32753690
[TBL] [Abstract][Full Text] [Related]
23. Half pint couples transcription and splicing of eIF4E-1,2 gene during fly development.
Reyes R; Izquierdo JM
Biochem Biophys Res Commun; 2008 Oct; 374(4):758-62. PubMed ID: 18671938
[TBL] [Abstract][Full Text] [Related]
24. A novel eIF4E-interacting protein that forms non-canonical translation initiation complexes.
Toribio R; Muñoz A; Castro-Sanz AB; Merchante C; Castellano MM
Nat Plants; 2019 Dec; 5(12):1283-1296. PubMed ID: 31819221
[TBL] [Abstract][Full Text] [Related]
25. Dual targeting of eIF4E by blocking MNK and mTOR pathways in leukemia.
Kosciuczuk EM; Saleiro D; Platanias LC
Cytokine; 2017 Jan; 89():116-121. PubMed ID: 27094611
[TBL] [Abstract][Full Text] [Related]
26. Mitosis-related phosphorylation of the eukaryotic translation suppressor 4E-BP1 and its interaction with eukaryotic translation initiation factor 4E (eIF4E).
Sun R; Cheng E; Velásquez C; Chang Y; Moore PS
J Biol Chem; 2019 Aug; 294(31):11840-11852. PubMed ID: 31201269
[TBL] [Abstract][Full Text] [Related]
27. Protein phosphatase 2A negatively regulates eukaryotic initiation factor 4E phosphorylation and eIF4F assembly through direct dephosphorylation of Mnk and eIF4E.
Li Y; Yue P; Deng X; Ueda T; Fukunaga R; Khuri FR; Sun SY
Neoplasia; 2010 Oct; 12(10):848-55. PubMed ID: 20927323
[TBL] [Abstract][Full Text] [Related]
28. Therapeutic approaches targeting splicing factor mutations in myelodysplastic syndromes and acute myeloid leukemia.
Figg JW; Barajas JM; Obeng EA
Curr Opin Hematol; 2021 Mar; 28(2):73-79. PubMed ID: 33492002
[TBL] [Abstract][Full Text] [Related]
29. RNA Splicing Alterations Induce a Cellular Stress Response Associated with Poor Prognosis in Acute Myeloid Leukemia.
Anande G; Deshpande NP; Mareschal S; Batcha AMN; Hampton HR; Herold T; Lehmann S; Wilkins MR; Wong JWH; Unnikrishnan A; Pimanda JE
Clin Cancer Res; 2020 Jul; 26(14):3597-3607. PubMed ID: 32122925
[TBL] [Abstract][Full Text] [Related]
30. Alternative transcriptional initiation and splicing define the translational efficiencies of zebrafish mRNAs encoding eukaryotic initiation factor 4E.
Fahrenkrug SC; Joshi B; Hackett PB; Jagus R
Differentiation; 2000 Aug; 66(1):15-22. PubMed ID: 10997588
[TBL] [Abstract][Full Text] [Related]
31. Oncofetal protein IGF2BP3 facilitates the activity of proto-oncogene protein eIF4E through the destabilization of EIF4E-BP2 mRNA.
Mizutani R; Imamachi N; Suzuki Y; Yoshida H; Tochigi N; Oonishi T; Suzuki Y; Akimitsu N
Oncogene; 2016 Jul; 35(27):3495-502. PubMed ID: 26522719
[TBL] [Abstract][Full Text] [Related]
32. High affinity RNA for mammalian initiation factor 4E interferes with mRNA-cap binding and inhibits translation.
Mochizuki K; Oguro A; Ohtsu T; Sonenberg N; Nakamura Y
RNA; 2005 Jan; 11(1):77-89. PubMed ID: 15611299
[TBL] [Abstract][Full Text] [Related]
33. Aberrant splicing and defective mRNA production induced by somatic spliceosome mutations in myelodysplasia.
Shiozawa Y; Malcovati L; Gallì A; Sato-Otsubo A; Kataoka K; Sato Y; Watatani Y; Suzuki H; Yoshizato T; Yoshida K; Sanada M; Makishima H; Shiraishi Y; Chiba K; Hellström-Lindberg E; Miyano S; Ogawa S; Cazzola M
Nat Commun; 2018 Sep; 9(1):3649. PubMed ID: 30194306
[TBL] [Abstract][Full Text] [Related]
34. Controlling gene expression through RNA regulons: the role of the eukaryotic translation initiation factor eIF4E.
Culjkovic B; Topisirovic I; Borden KL
Cell Cycle; 2007 Jan; 6(1):65-9. PubMed ID: 17245113
[TBL] [Abstract][Full Text] [Related]
35. The nematode eukaryotic translation initiation factor 4E/G complex works with a trans-spliced leader stem-loop to enable efficient translation of trimethylguanosine-capped RNAs.
Wallace A; Filbin ME; Veo B; McFarland C; Stepinski J; Jankowska-Anyszka M; Darzynkiewicz E; Davis RE
Mol Cell Biol; 2010 Apr; 30(8):1958-70. PubMed ID: 20154140
[TBL] [Abstract][Full Text] [Related]
36. A biochemical framework for eIF4E-dependent mRNA export and nuclear recycling of the export machinery.
Volpon L; Culjkovic-Kraljacic B; Sohn HS; Blanchet-Cohen A; Osborne MJ; Borden KLB
RNA; 2017 Jun; 23(6):927-937. PubMed ID: 28325843
[TBL] [Abstract][Full Text] [Related]
37. Repressor binding to a dorsal regulatory site traps human eIF4E in a high cap-affinity state.
Ptushkina M; von der Haar T; Karim MM; Hughes JM; McCarthy JE
EMBO J; 1999 Jul; 18(14):4068-75. PubMed ID: 10406811
[TBL] [Abstract][Full Text] [Related]
38. Clinicopathologic characterisation of myeloid neoplasms with concurrent spliceosome mutations and myeloproliferative-neoplasm-associated mutations.
Liu YC; Illar GM; Bailey NG
J Clin Pathol; 2020 Nov; 73(11):728-736. PubMed ID: 32217616
[TBL] [Abstract][Full Text] [Related]
39. Targeting of phospho-eIF4E by homoharringtonine eradicates a distinct subset of human acute myeloid leukemia.
Zhou H; Xu RZ; Gu Y; Shi PF; Qian S
Leuk Lymphoma; 2020 May; 61(5):1084-1096. PubMed ID: 29334312
[TBL] [Abstract][Full Text] [Related]
40. Eukaryotic translation initiation factor 4E as a novel therapeutic target in hematological malignancies and beyond.
Pettersson F; Del Rincon SV; Miller WH
Expert Opin Ther Targets; 2014 Sep; 18(9):1035-48. PubMed ID: 25004955
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
